About Us

Governor Brownback

The Midwest Stem Cell Therapy Center (MSCTC) was created by the Kansas Legislature in the 2013 session, with a state appropriation. Philanthropic funding will also be accepted through the KU Endowment Association.

The law creating the center took effect on July 1, 2013. KU Medical Center Executive Vice Chancellor Douglas Girod, M.D. appointed Buddhadeb Dawn, M.D., to serve as the center's executive director. A 15-member advisory has been assembled, with members appointed by the governor, the House, the Senate, the Board of Regents and several other stakeholder entities throughout the state.

Adult stem cell treatments have been used clinically to successfully treat leukemia and related bone/blood cancers using bone marrow transplantation. KU Medical Center has been involved in research using the solid part of the umbilical cord (Wharton's jelly).

the university of kansas

Besides KU Medical Center, other institutions around the state have also initiated adult stem cell research projects. However, before the MSCTC, there was no systematic mechanism for Kansans to receive adult stem cell therapy (other than bone marrow transplants for a few conditions) in the state or in the region, nor was there a coordinated center to translate basic stem cell research findings into clinical applications. There is also a lack of knowledge among the public as well as medical professionals about adult stem cell therapeutic options, currently available or in development, that could benefit Kansans and other patients in need.

In addition to bone marrow transplantation, additional therapies with adult stem cells - including organ repair - have been the focus of intense attention in the scientific community in recent years.

as adult stem cell therapy is becoming more effective, many patients will benefit. Kansas is well-positioned to contribute to this burgeoning new field of medicine. Kansas has the opportunity to focus on development of specific areas of adult stem cell research and patient treatment, with the potential to become a world leader in patient therapies for specific diseases or conditions.

Last modified: Apr 15, 2015
I want to...